Kidney Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Kidney Disease stocks.

Kidney Disease Stocks Recent News

Date Stock Title
May 23 FGEN FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) at the 2024 American Society of Clinical Oncol...
May 23 BAX Baxter to Present at Jefferies 2024 Global Healthcare Conference
May 23 CALT Calliditas Therapeutics AB (publ) (CALT) Q1 2024 Earnings Call Transcript
May 23 AZN Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity
May 23 AZN Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
May 23 AZN AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)
May 23 CALT Calliditas Therapeutics AB (publ) 2024 Q1 - Results - Earnings Call Presentation
May 23 AZN AstraZeneca and Nona Biosciences sign agreement for monoclonal antibody
May 23 AKBA Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference
May 23 AZN Nona Biosciences and AstraZeneca sign global license and option agreement
May 23 CALT Calliditas Q1 report, January - March 2024
May 22 AZN Why Astrazeneca (AZN) is a Great Dividend Stock Right Now
May 22 AZN Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
May 22 ARDX Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
May 22 AZN AstraZeneca furthers ambition to transform outcomes in early lung cancer and ​redefine metastatic breast cancer treatment at ASCO 2024​
May 22 AZN SixPeaks, a new obesity biotech, starts up with an option to sell to AstraZeneca
May 21 AZN AstraZeneca’s $80B sales plan leans on cancer drug expansion
May 21 AZN AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
May 21 AZN European Equities Close Lower in Tuesday Trading; AstraZeneca Targets $80 Billion in Revenue by 2030
May 21 AZN AstraZeneca sets sights on $80B in revenue by 2030
Kidney Disease

Kidney disease is a condition in which the kidneys are damaged and unable to filter waste and toxins from the blood. This can lead to a buildup of waste and toxins in the body, which can cause a variety of symptoms, including fatigue, nausea, loss of appetite, and swelling in the hands and feet. In severe cases, kidney disease can lead to kidney failure, which requires dialysis or a kidney transplant.

Browse All Tags